Zacks: Ashford Inc. (AINC) Given $89.00 Average Target Price by Brokerages

Share on StockTwits

Ashford Inc. (NASDAQ:AINC) has received a consensus broker rating score of 1.00 (Strong Buy) from the two brokers that cover the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy recommendation. Ashford’s rating score has improved by 66.7% from three months ago as a result of various analysts’ ratings changes.

Brokerages have set a 12-month consensus price target of $89.00 for the company and are anticipating that the company will post $1.17 EPS for the current quarter, according to Zacks. Zacks has also given Ashford an industry rank of 161 out of 257 based on the ratings given to related companies.

Separately, B. Riley raised shares of Ashford from a “neutral” rating to a “buy” rating and dropped their price target for the company from $95.00 to $91.00 in a research report on Thursday, October 11th.

Shares of NASDAQ AINC opened at $59.02 on Tuesday. Ashford has a 1 year low of $53.00 and a 1 year high of $106.00.

Ashford (NASDAQ:AINC) last issued its quarterly earnings data on Thursday, November 1st. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($1.71) by $1.89. The business had revenue of $41.57 million for the quarter, compared to analyst estimates of $37.56 million.

Ashford Company Profile

Ashford, Inc is an asset management firm. The firm provides investment management and related services to the real estate and hospitality sectors. Ashford, Inc was formed on April 2, 2014 and is based in Dallas, Texas.

Featured Story: Analyzing a company’s cash flow statement

Get a free copy of the Zacks research report on Ashford (AINC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Ashford Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashford and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.